Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease-Reference-Cited by-同舟云学术

Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease

Published:2016-08-29 Issue:11 Volume:96 Page:1147-1155
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Mancinelli Romina,Franchitto Antonio,Glaser Shannon,Vetuschi Antonella,Venter Julie,Sferra Roberta,Pannarale Luigi,Olivero Francesca,Carpino Guido,Alpini Gianfranco,Onori Paolo^ORCID,Gaudio Eugenio

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest201693.pdf

Reference53 articles.

1. Armstrong SP, Seeber RM, Ayoub MA et al.Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V). PLoS One 2013;8:e65885.

2. Serriere V, Tran D, Stelly N et al.Vasopressin-induced morphological changes in polarized rat hepatocyte multiplets: dual calcium-dependent effects. Cell Calcium 2008;43:95–104.

3. Nicou A, Serriere V, Prigent S et al.Hypothalamic vasopressin release and hepatocyte Ca2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow. FASEB J 2003;17:1901–1903.

4. Koshimizu TA, Nakamura K, Egashira N et al.Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 2012;92:1813–1864.

5. Serriere V, Berthon B, Boucherie S et al.Vasopressin receptor distribution in the liver controls calcium wave propagation and bile flow. FASEB J 2001;15:1484–1486.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment;Hepatic Medicine: Evidence and Research;2022-09

2. dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells;Frontiers in Cell and Developmental Biology;2022-07-08

3. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease;Nature Reviews Gastroenterology & Hepatology;2022-05-13

4. Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis;Drug Delivery and Translational Research;2022-02-28

5. Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use;PLOS ONE;2022-02-17